Meeting
Abstract Number: 491
SHM Converge 2023
Case Presentation: A 77-year-old female with breast cancer on capecitabine (Xeloda) initiated 3 weeks ago presented with mouth pain and diarrhea for the last 10 days. She denied any fevers, sick contacts, or recent antibiotic use. Her last dose of capecitabine was 1 week prior. On arrival, she was hypotensive and tachycardic; physical exam was […]
Abstract Number: 585
SHM Converge 2023
Case Presentation: An 89-year-old female patient with a medical history of atrial fibrillation, TIA, and colon cancer stage IV for which she started Capecitabine three days before her presentation. She presented to the emergency department with intermittent chest pain that started the next day of starting Capecitabine. She was afebrile; her respiratory rate was 18, […]
Abstract Number: 648
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Case Presentation: 52-year-old female with history of Stage IIIA triple negative right sided breast cancer, seizure disorder, and s/p lumpectomy presents with ataxia, confusion, and dyskinesia over the past 2 weeks. The patient is chronically on phenytoin, ondansetron, paroxetine, and potassium supplements. She has been on phenytoin since her last seizure three years ago. She […]
Abstract Number: 756
SHM Converge 2024
Case Presentation: A 78-year-old female with a history of breast cancer and pancreatic cancer, with status post Whipple procedure and started with capecitabine one month prior to admission, severe malnutrition, started on a high-protein diet one month prior, presented with acute encephalopathy. Her symptoms started acutely as confusion, then progressed to somnolence. She was alert […]